Renaissance Technologies’s Enliven Therapeutics ELVN Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $479K | Buy |
23,900
+12,000
| +101% | +$241K | ﹤0.01% | 2851 |
|
|
2025
Q1 | $234K | Buy |
+11,900
| New | +$234K | ﹤0.01% | 3028 |
|
|
2023
Q3 | – | Sell |
-36,150
| Closed | -$738K | – | 3761 |
|
|
2023
Q2 | $738K | Sell |
36,150
-34,108
| -49% | -$696K | ﹤0.01% | 2665 |
|
|
2023
Q1 | $1.54M | Buy |
70,258
+16,808
| +31% | +$368K | ﹤0.01% | 2194 |
|
|
2022
Q4 | $874K | Sell |
53,450
-28,881
| -35% | -$472K | ﹤0.01% | 2609 |
|
|
2022
Q3 | $751K | Sell |
82,331
-19,549
| -19% | -$178K | ﹤0.01% | 2667 |
|
|
2022
Q2 | $497K | Sell |
101,880
-10,745
| -10% | -$52.4K | ﹤0.01% | 3169 |
|
|
2022
Q1 | $847K | Buy |
112,625
+2,725
| +2% | +$20.5K | ﹤0.01% | 2835 |
|
|
2021
Q4 | $989K | Buy |
109,900
+41,325
| +60% | +$372K | ﹤0.01% | 2645 |
|
|
2021
Q3 | $1.12M | Buy |
68,575
+58,633
| +590% | +$957K | ﹤0.01% | 2485 |
|
|
2021
Q2 | $314K | Buy |
+9,942
| New | +$314K | ﹤0.01% | 3133 |
|
|
2020
Q4 | – | Sell |
-3,056
| Closed | -$249K | – | 3456 |
|
|
2020
Q3 | $249K | Sell |
3,056
-191
| -6% | -$15.6K | ﹤0.01% | 3057 |
|
|
2020
Q2 | $359K | Buy |
+3,247
| New | +$359K | ﹤0.01% | 2983 |
|